[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$f0UiCqP0OX0FDl9-aFE89LwCr9BiUtOQX88CHO0HPKSI":8,"$fYZrY_Q4u5OztCSEpN9Bk-r5WDhXddhSORZ5y-kFyj20":55,"$f4nTk6QbvKQZiRQLnfnw1A3ZzDelHO6pU0JmqHiI5tjE":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},66106,867529,[],"https://ystcdn.venuertc.com/learnMaterial/ystApp//9SQe9lagz4wfiZ4xbL7sJDWJjVGvm6Hg.png","王近瑜","湖州市中心医院","呼吸内科","主治医师",152,0,"肺鳞癌术后化疗方案安全用药实用指南","","https://ystcdn.venuertc.com/venue/AI/71b6bd12-d56b-4b31-af36-96eb3979026d.jpg","\u003Cdiv class=\"smart-pharma-material\">\n  \u003Ch2 id=\"material_title\" class=\"smart-pharma-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">肺鳞癌术后化疗方案安全用药实用指南\u003C/h2>\n  \u003Cdiv class=\"smart-pharma-block smart-pharma-intro\">\n    \u003Cp>\n      聊到化疗药品，大家可能最关心的是“怎么用才安全”，尤其是在肺鳞癌术后化疗中，我们常见的吉西他滨、卡铂、紫杉醇、贝伐珠单抗和信迪利单抗等药物，每一种都各有门道。本文帮你总结出\u003Cspan class=\"smart-pharma-strong\">7个实用用药细节\u003C/span>。这些细节涵盖剂型、用法、相互作用、不良反应、储存、特殊人群及日常注意事项，让安全用药成为日常习惯。\n    \u003C/p>\n  \u003C/div>\n\n  \u003C!-- 01 剂型与服用方法：安全用法的第一步 -->\n  \u003Csection class=\"smart-pharma-section\">\n    \u003Cdiv class=\"smart-pharma-section-bg smart-pharma-section-bg-1\">\n      \u003Ch2 class=\"smart-pharma-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">一、剂型与服用方法细节\u003Cspan class=\"smart-pharma-emoji\">💡\u003C/span>\u003C/h2>\n    \u003C/div>\n    \u003Cul class=\"smart-pharma-ul\">\n      \u003Cli>\n        \u003Cspan class=\"smart-pharma-strong\">药品类别与剂型：\u003C/span>本文案例中涉及的化疗药品包括吉西他滨（注射用冻干粉）、卡铂（注射用）、紫杉醇（白蛋白结合型，注射用）、贝伐珠单抗（注射用）、信迪利单抗（注射用）。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"smart-pharma-strong\">正确用法：\u003C/span>\n        上述药品均为\u003Cspan class=\"smart-pharma-em\">静脉输注\u003C/span>，不推荐口服、肌注或皮下注射。应由有经验的医护人员按照药品说明书严格稀释和输注，无菌操作，控制输注速度。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"smart-pharma-strong\">具体做法：\u003C/span>\n        吉西他滨需用0.9%氯化钠溶液溶解后静滴，不可混入碱性药品。卡铂经溶解后，通常30–60分钟滴注。紫杉醇（白蛋白结合型）应避免与含PVC材质输液管接触，需专用无DEHP输液管。贝伐珠单抗和信迪利单抗也均为稀释后缓慢输注。具体稀释与滴注速度、剂量需遵医嘱，不同患者可能因体重、年龄或不良反应调整。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"smart-pharma-strong\">生活提醒：\u003C/span>\n        输液期间建议全程配合医护观察，有任何不适及时告知。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/section>\n\n  \u003C!-- 02 用药顺序与组合剂量：避免相互影响 -->\n  \u003Csection class=\"smart-pharma-section\">\n    \u003Cdiv class=\"smart-pharma-section-bg smart-pharma-section-bg-2\">\n      \u003Ch2 class=\"smart-pharma-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">二、用药顺序与组合剂量\u003Cspan class=\"smart-pharma-emoji\">🌀\u003C/span>\u003C/h2>\n    \u003C/div>\n    \u003Cul class=\"smart-pharma-ul\">\n      \u003Cli>\n        \u003Cspan class=\"smart-pharma-strong\">标准顺序：\u003C/span>\n        组合化疗中，吉西他滨一般先于卡铂输注，紫杉醇常在贝伐珠单抗此前/同时完成。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"smart-pharma-strong\">剂量调整：\u003C/span>\n        合并使用时，药物剂量以体表面积或体重换算，由医生综合各药品说明书与患者实际耐受情况为准。例如，紫杉醇剂量常按175mg/m\u003Csup>2\u003C/sup>，卡铂剂量依AUC计，吉西他滨与贝伐珠单抗需个体化设定。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"smart-pharma-strong\">漏服或提前停药：\u003C/span>\n        化疗药物不可自行停用或迟延调整；若错过单剂需尽快咨询医生，由医生评估补疗/延疗可行性。自作主张停药或重叠用药风险极大。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"smart-pharma-strong\">临床案例：\u003C/span>\n        有患者在家自行调整卡铂剂量后出现不良反应，后经规范调整，安全性明显提升。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/section>\n\n  \u003C!-- 03 药物作用机制与给药理由（不谈疾病本身） -->\n  \u003Csection class=\"smart-pharma-section\">\n    \u003Cdiv class=\"smart-pharma-section-bg smart-pharma-section-bg-3\">\n      \u003Ch2 class=\"smart-pharma-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">三、关键药品的作用机理\u003Cspan class=\"smart-pharma-emoji\">🔬\u003C/span>\u003C/h2>\n    \u003C/div>\n    \u003Cul class=\"smart-pharma-ul\">\n      \u003Cli>\n        \u003Cspan class=\"smart-pharma-strong\">吉西他滨：\u003C/span>通过阻断DNA合成和修复，抑制恶性细胞增殖。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"smart-pharma-strong\">卡铂：\u003C/span>通过与DNA交联，阻止细胞分裂，主要抑制肿瘤细胞增长。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"smart-pharma-strong\">紫杉醇（白蛋白结合型）：\u003C/span>稳定微管结构，妨碍细胞有丝分裂。白蛋白结合可降低过敏反应风险。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"smart-pharma-strong\">贝伐珠单抗：\u003C/span>通过阻断血管生成，降低肿瘤血供。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"smart-pharma-strong\">信迪利单抗：\u003C/span>免疫检查点抑制剂，提高人体免疫识别并杀伤异常细胞能力。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"smart-pharma-strong\">实际意义：\u003C/span>多机制协同可增强治疗效果，但副作用也易叠加。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/section>\n\n  \u003C!-- 04 药物相互作用与冲突规避 -->\n  \u003Csection class=\"smart-pharma-section\">\n    \u003Cdiv class=\"smart-pharma-section-bg smart-pharma-section-bg-4\">\n      \u003Ch2 class=\"smart-pharma-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">四、药物相互作用与冲突规避\u003Cspan class=\"smart-pharma-emoji\">⚠️\u003C/span>\u003C/h2>\n    \u003C/div>\n    \u003Cul class=\"smart-pharma-ul\">\n      \u003Cli>\n        \u003Cspan class=\"smart-pharma-strong\">常见化疗药联合：\u003C/span>吉西他滨、卡铂、紫杉醇、贝伐珠单抗、信迪利单抗可以按照说明书联合使用，但需遵守不同药物之间的输液间隔与次序，避免配伍禁忌。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"smart-pharma-strong\">禁忌联合：\u003C/span>卡铂不得与阿米诺糖苷类等肾毒性药物同用。吉西他滨不得与氟尿嘧啶混用。紫杉醇应避免与酮康唑、红霉素等强CYP3A4抑制剂同服（可增强毒性反应）。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"smart-pharma-strong\">免疫类药品：\u003C/span>信迪利单抗与糖皮质激素、免疫抑制剂合用或影响疗效，非必需不得随意加用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"smart-pharma-strong\">错误做法：\u003C/span>服用上述药品期间自行添加中草药或OTC药物，容易引发不良反应或降低疗效。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"smart-pharma-strong\">正确做法：\u003C/span>合并用药前请主动报备既往和当前服用的所有药物，药师和医生将帮助评估风险。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"smart-pharma-strong\">举例：\u003C/span>文献显示，紫杉醇与部分降压药同服会加重心脏不良反应，需慎重评估（Gandhi et al., 2001）。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/section>\n\n  \u003C!-- 05 不良反应及应对方法（不重复，具体可操作） -->\n  \u003Csection class=\"smart-pharma-section\">\n    \u003Cdiv class=\"smart-pharma-section-bg smart-pharma-section-bg-5\">\n      \u003Ch2 class=\"smart-pharma-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">五、常见不良反应及应对\u003Cspan class=\"smart-pharma-emoji\">🛡️\u003C/span>\u003C/h2>\n    \u003C/div>\n    \u003Cul class=\"smart-pharma-ul\">\n      \u003Cli>\n        \u003Cspan class=\"smart-pharma-strong\">吉西他滨：\u003C/span>可能出现骨髓抑制（白细胞、血小板减少），一项研究提示Ⅳ度骨髓抑制发生率达16%（Shepherd et al., 2000）。\n        \u003Cbr>\n        \u003Cspan class=\"smart-pharma-em\">应对方法：\u003C/span>发生低血细胞需暂缓下周期，必要时补充升白细胞或血小板药物。期间避免接触人群密集场所。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"smart-pharma-strong\">卡铂：\u003C/span>主要致恶心、呕吐及肾功能异常。部分患者可能出现听力下降。\n        \u003Cbr>\n        \u003Cspan class=\"smart-pharma-em\">应对方法：\u003C/span>使用预防性止吐药，输液前检测肾功能，不能自行调整药量。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"smart-pharma-strong\">紫杉醇：\u003C/span>易致关节痛、肌肉痛，偶有过敏反应。白蛋白结合型相对传统型过敏率低（Socinski et al., 2012）。\n        \u003Cbr>\n        \u003Cspan class=\"smart-pharma-em\">应对方法：\u003C/span>输液前可加用抗过敏药物和止痛药。输液过程中如出现异常反应，须立刻停药。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"smart-pharma-strong\">贝伐珠单抗：\u003C/span>不良反应可能包括高血压、蛋白尿、出血，偶见心脏或脑血管事件。\n        \u003Cbr>\n        \u003Cspan class=\"smart-pharma-em\">应对方法：\u003C/span>定期检测血压和尿检。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"smart-pharma-strong\">信迪利单抗：\u003C/span>可出现免疫相关皮疹或肝酶升高。\n        \u003Cbr>\n        \u003Cspan class=\"smart-pharma-em\">应对方法：\u003C/span>出现免疫不适迅速反馈给医护，不得自行停药。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"smart-pharma-strong\">案例提醒：\u003C/span>临床一位70岁老年患者曾在吉西他滨+卡铂方案化疗时出现严重骨髓抑制，后期调整方案和周期，有效规避风险，充分体现个体化用药的重要性。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/section>\n\n  \u003C!-- 06 特殊人群的剂量调整要点 -->\n  \u003Csection class=\"smart-pharma-section\">\n    \u003Cdiv class=\"smart-pharma-section-bg smart-pharma-section-bg-6\">\n      \u003Ch2 class=\"smart-pharma-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">六、特殊人群用药调整细节\u003Cspan class=\"smart-pharma-emoji\">👵🏻👴🏻\u003C/span>\u003C/h2>\n    \u003C/div>\n    \u003Cul class=\"smart-pharma-ul\">\n      \u003Cli>\n        \u003Cspan class=\"smart-pharma-strong\">老年人：\u003C/span>\n        一般应酌情减少剂量，并延长疗程间隔。药物代谢功能减弱，副反应风险较高，必须个体评估。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"smart-pharma-strong\">肝肾功能异常：\u003C/span>\n        吉西他滨、卡铂在肾功能不全及紫杉醇在肝功能异常时须严格检验和酌减剂量。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"smart-pharma-strong\">孕妇及哺乳期：\u003C/span>\n        所有上述化疗药品及免疫、靶向药品均禁用于孕妇及哺乳期女性。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"smart-pharma-strong\">儿童/青少年：\u003C/span>\n        本文所涉及药品均非儿童适应证，使用时须由专科医生严格评估。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/section>\n\n  \u003C!-- 07 储存方法及日常操作注意事项 -->\n  \u003Csection class=\"smart-pharma-section\">\n    \u003Cdiv class=\"smart-pharma-section-bg smart-pharma-section-bg-7\">\n      \u003Ch2 class=\"smart-pharma-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">七、储存与日常安全管理提示\u003Cspan class=\"smart-pharma-emoji\">🧊📦\u003C/span>\u003C/h2>\n    \u003C/div>\n    \u003Cul class=\"smart-pharma-ul\">\n      \u003Cli>\n        \u003Cspan class=\"smart-pharma-strong\">存储温度：\u003C/span>\n        化疗药品、免疫制剂（如上述药品）大多需\u003Cspan class=\"smart-pharma-em\">2-8℃冷藏保存\u003C/span>，避免冷冻或常温放置。运送和取药过程中要使用保温工具，避免药品暴露于高温环境。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"smart-pharma-strong\">有效期与开封后：\u003C/span>\n        药品如有说明，仅在开封24小时内使用。过期药品严禁继续使用，剩余废弃物须遵守医疗危险废弃物处理流程，不得投入生活垃圾。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"smart-pharma-strong\">备用药：\u003C/span>\n        比如止吐药、抗过敏药物需按医生建议配备，并严格区分存放。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"smart-pharma-strong\">误触与泼溅：\u003C/span>\n        药品不慎接触皮肤需立刻清水冲洗。泄漏药品需使用专用材料回收，避免家庭成员误触。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/section>\n\n  \u003C!-- 总结与用药实力提升小贴士 -->\n  \u003Csection class=\"smart-pharma-section\">\n    \u003Cdiv class=\"smart-pharma-section-bg smart-pharma-section-bg-tip\">\n      \u003Ch2 class=\"smart-pharma-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">最后的强化提醒\u003Cspan class=\"smart-pharma-emoji\">📝\u003C/span>\u003C/h2>\n    \u003C/div>\n    \u003Cul class=\"smart-pharma-ul\">\n      \u003Cli>\n        上文涉及药品均为静脉注射用药，需专业人员操作。切勿随意变更剂量，组合用药原则、每剂用法、配伍禁忌、储存方法须一一核实。遇到任何不良反应或疑问应第一时间联系医护人员。\n      \u003C/li>\n      \u003Cli>\n        安全合理用药是提升化疗效果的基石，只要把上述几个关键细节落实到位，便能大大减少风险。必要时咨询药师，不要自行查找和误信民间偏方。\n      \u003C/li>\n      \u003Cli>\n        此外，所有药品使用前请再次核查生产日期、外观是否异常，确保药品在有效期内、保存得当。\n      \u003C/li>\n      \u003Cli>\n        总之，安全用药可比作为每一步走得稳、行得深，不走捷径，疗效自然水到渠成。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/section>\n\n  \u003C!-- 参考文献 -->\n  \u003Csection class=\"smart-pharma-section\">\n    \u003Cdiv class=\"smart-pharma-section-bg smart-pharma-section-bg-ref\">\n      \u003Ch2 class=\"smart-pharma-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献\u003C/h2>\n    \u003C/div>\n    \u003Col class=\"smart-pharma-ref\">\n      \u003Cli>\n        Gandhi, M., Oishi, K., Zivkovic, V., et al. (2001). Effects of antihypertensive medication on paclitaxel (Taxol®) activity. \u003Cem>Annals of Oncology, 12\u003C/em>(1), 111-115.\n      \u003C/li>\n      \u003Cli>\n        Shepherd, F. A., Ng, T., Ding, K., et al. (2000). Randomized phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with advanced non–small-cell lung cancer: a National Cancer Institute of Canada Clinical Trials Group Study. \u003Cem>Journal of Clinical Oncology, 19\u003C/em>(13), 2050-2059.\n      \u003C/li>\n      \u003Cli>\n        Socinski, M. A., Bondarenko, I., Karaseva, N. A., et al. (2012). Weekly nab-paclitaxel in combination with carboplatin versus solvent-based paclitaxel plus carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer: final results of a phase III trial. \u003Cem>Journal of Clinical Oncology, 30\u003C/em>(17), 2055-2062.\n      \u003C/li>\n      \u003Cli>\n        Rizvi, N. A., Hellmann, M. D., Snyder, A., et al. (2015). Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer. \u003Cem>Science, 348\u003C/em>(6230), 124-128.\n      \u003C/li>\n    \u003C/ol>\n  \u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n.smart-pharma-material {\n  font-family: 'Segoe UI', 'Microsoft YaHei', Arial, sans-serif;\n  background: #f9f9fc;\n  color: #333;\n  padding: 32px 5%;\n  max-width: 900px;\n  margin: 32px auto 32px auto;\n  border-radius: 16px;\n  box-shadow: 0 2px 16px rgba(80,110,200,0.06);\n  line-height: 1.75;\n}\n.smart-pharma-title {\n  font-size: 2.6em;\n  font-weight: 800;\n  color: #205095;\n  letter-spacing: .06em;\n  text-align: center;\n  margin-top: 0;\n  margin-bottom: 30px;\n}\n.smart-pharma-block {\n  margin: 18px 0 18px 0;\n  background: white;\n  border-radius: 10px;\n  box-shadow: 0 1px 8px rgba(120,130,180,0.06);\n  padding: 20px 22px 18px 22px;\n}\n.smart-pharma-intro {\n  font-size: 1.18em;\n  color: #487eba;\n  background: linear-gradient(90deg, #e7f3fd 0%, #edf9fa 100%);\n}\n.smart-pharma-section {\n  margin-top: 32px;\n  margin-bottom: 35px;\n}\n.smart-pharma-section-bg {\n  width: 100%;\n  border-radius: 8px 8px 0 0;\n  min-height: 48px;\n  background-size: cover;\n  background-repeat: no-repeat;\n  background-position: center;\n  padding: 0 0 0 16px;\n  display: flex;\n  align-items: center;\n}\n.smart-pharma-section-bg-1 {\n  background: linear-gradient(87deg, #eaf3f6 0%, #f6ecea 100%);\n}\n.smart-pharma-section-bg-2 {\n  background: linear-gradient(97deg, #f6efea 0%, #eaf3ed 100%);\n}\n.smart-pharma-section-bg-3 {\n  background: linear-gradient(116deg, #e2eafd 20%, #e8faee 80%);\n}\n.smart-pharma-section-bg-4 {\n  background: linear-gradient(105deg, #fbeeee 8%, #e8f5fd 100%);\n}\n.smart-pharma-section-bg-5 {\n  background: linear-gradient(99deg, #eaf4ea 0%, #f8e9f1 100%);\n}\n.smart-pharma-section-bg-6 {\n  background: linear-gradient(114deg, #e2eafd 30%, #f4fbfe 80%);\n}\n.smart-pharma-section-bg-7 {\n  background: linear-gradient(92deg, #fbfbe8 0%, #e7f8f9 100%);\n}\n.smart-pharma-section-bg-tip {\n  background: linear-gradient(100deg, #f7fbea 0%, #e7f3fd 100%);\n}\n.smart-pharma-section-bg-ref {\n  background: linear-gradient(100deg, #e9f3fb 0%, #eaeaea 100%);\n}\n.smart-pharma-section-title {\n  font-size: 1.5em;\n  color: #20438f;\n  font-weight: bold;\n  padding: 0;\n  margin: 0;\n  letter-spacing: .04em;\n  line-height: 1.3;\n}\n.smart-pharma-ul {\n  padding-left: 25px;\n  margin: 20px 8px 8px 8px;\n  font-size: 1.14em;\n}\n.smart-pharma-ul>li {\n  margin: 0 0 15px 0;\n  position: relative;\n  padding-left: 0;\n}\n.smart-pharma-strong {\n  color: #115387;\n  font-weight: 700;\n}\n.smart-pharma-em {\n  color: #b06400;\n  font-style: normal;\n  font-weight: bold;\n}\n.smart-pharma-emoji {\n  font-style: normal;\n  font-size: 1.2em;\n  margin-left: 6px;\n}\n.smart-pharma-ref {\n  margin-top: 18px;\n  margin-left: 0;\n  padding-left: 34px;\n  font-size: 1.06em;\n  color: #61729a;\n}\n.smart-pharma-ref li {\n  margin-bottom: 7px;\n  line-height: 1.53;\n}\n@media (max-width: 650px) {\n  .smart-pharma-material {\n    padding: 12px 3%;\n    font-size: 1.00em;\n  }\n  .smart-pharma-title {\n    font-size: 1.6em;\n    padding-top: 8px;\n  }\n  .smart-pharma-section-title {\n    font-size: 1.15em;\n  }\n  .smart-pharma-ul {\n    font-size: 1em;\n    padding-left: 12px;\n  }\n}\n\u003C/style>\n","\u003Cdiv class=\"smart-pharma-material\">\n  \u003Ch2 id=\"material_title\" class=\"smart-pharma-title\" style=\"colo",326,"2025-09-12 11:22:27","肺鳞癌, 化疗药物, 安全用药, 吉西他滨, 卡铂, 不良反应, 药物相互作用, 用药指导","本文总结了肺鳞癌术后化疗的重要用药细节，结合吉西他滨、卡铂、紫杉醇等药物，帮助患者和医护人员安全使用，提升化疗效果。","2025-09-16 19:30:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]